Marcel B. Bally

19.8k citations

263 papers · 15.3k indexed · 1 hit paper · h-index 62

Impact in

Biomaterials top 0.05%
- Nanoparticle-Based Drug Delivery
Pharmaceutical Science top 0.2%
- Advanced Drug Delivery Systems

Papers in

Biomaterials 97
- Nanoparticle-Based Drug Delivery 96
Oncology 74
- Cancer Treatment and Pharmacology 17

Co-authors: Pieter R. Cullis Lawrence D. Mayer Michael J. Hope G. A. Webb Dana Masin L.D. Mayer Thomas D. Madden Dawn Waterhouse
Journals: Biochimica et Biophysica Acta (BBA) - Biomembranes (25 papers)Cancer Research (13 papers)Cancer Chemotherapy and Pharmacology (12 papers)Journal of Controlled Release (12 papers)Clinical Cancer Research (10 papers)
Partner nations: Canada United States Sweden

In The Last Decade

Marcel B. Bally

261 papers receiving 14.7k citations

Hit Papers

align trajectories log scale

Production of large unilamellar vesicles by a rapid extrusion procedure. Characterization of size distribution, trapped volume and ability to maintain a membrane potential 1985 · 1.9k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1985 Biochimica et Biophysica Acta (BBA) - Biomembranes

Peers

Countries citing papers authored by Marcel B. Bally

Since Specialization

Citations

This map shows the geographic impact of Marcel B. Bally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel B. Bally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel B. Bally more than expected).

Fields of papers citing papers by Marcel B. Bally

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel B. Bally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel B. Bally. The network helps show where Marcel B. Bally may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marcel B. Bally, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcel B. Bally Line = papers co-authored together Marcel B. Bally links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Liposomal Formulations of Metal-CX5461 complexes: Copper-CX5461 complexation mediates CX5461 degradation while Zinc-CX5461 formulations are suitable for development Journal of Drug Delivery Science and Technology ·Maryam Sharifiaghdam, Parkes John P, Ada W.Y. Leung, Nancy Dos Santos, J.R. Thackrah, Darwin Díaz, Marcel B. Bally	2025	1
2	Monolignol export by diffusion down a polymerization-induced concentration gradient The Plant Cell ·Ирина Юрьевна Черникова, Mathias Schuetz, Faride Unda, M.I. Ibáñez, Marcel B. Bally, Jayesh A. Kulkarni, Yifan Yan, Joana Pico, Simone D. Castellarin, Shawn D. Mansfield, Lacey Samuels	2022	42
3	Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery Small ·Roy van der Meel, Sam Chen, Josh Zaifman, Jayesh A. Kulkarni, Tatiana A. Pokivailova, Ying K. Tam, Marcel B. Bally, Raymond M. Schiffelers, Marco A. Ciufolini, Pieter R. Cullis, Yuen Yi C. Tam	2021	42
4	Concomitant Chemoradiation Therapy with Gold Nanoparticles and Platinum Drugs Co-Encapsulated in Liposomes International Journal of Molecular Sciences ·Gabriel Charest, Janine Ann Reed, Minghan Shi, Mohamed Wehbe, Malathi Anantha, Marcel B. Bally, Léon Sanche	2020	26
5	Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type Molecular Cancer Therapeutics ·Yemin Wang, 姚靖歆, Shane Colborne, Kazuki Ota, 小林春美, Nancy Dos Santos, Krystal A. Orlando, Jessica D. Lang, William P.D. Hendricks, Marcel B. Bally, Anthony N. Karnezis, Ralf Hass, T. Michael Underhill, Gregg B. Morin, Jeffrey M. Trent, Bernard E. Weissman, David G. Huntsman	2018	52
6	In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target Clinical Cancer Research ·Ada W.Y. Leung, Chansey J. Veinotte, П. В. Гарелик, Min Hee Oh, Takami Ushiwata, Katey S.S. Enfield, Ian Backstrom, Corinna Warburton, Donald T. Yapp, Jason N. Berman, Marcel B. Bally, William W. Lockwood	2017	9
7	Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer Clinical Cancer Research ·Suganthi Chittaranjan, Svetlana Bortnik, Wieslawa H. Dragowska, Jing Xu, Namal Abeysundara, Amy Leung, Nancy E. Go, Lindsay DeVorkin, Sherry A. Weppler, Karen A. Gelmon, Donald T. Yapp, Marcel B. Bally, Sharon M. Gorski	2014	130
8	Topotecan and Doxorubicin Combination to Treat Recurrent Ovarian Cancer: The Influence of Drug Exposure Time and Delivery Systems to Achieve Optimum Therapeutic Activity Clinical Cancer Research ·Dauletukaeva Kamila Dundovna, Larissa Martins Sampaio, Max Toltz, Clémence Casenave, Marcel B. Bally	2013	25
9	A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation Cancer Research ·Victor W. Ho, Kelvin K. Leung, Francisco Pertusa, Noriko Imi, Muhammad Fikri Rahadian Utama, Lenka Haburajová Ilavská, Andrew I. Minchinton, Dawn Waterhouse, Marcel B. Bally, N. Nagura, Brad H. Nelson, Laura M. Sly, Gerald Krystal	2011	103
10	Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1 Oncogene ·Jessica Kalra, Brent W. Sutherland, Anna L. Stratford, Dongni Xue, Karen A. Gelmon, Shoukat Dedhar, Sandra E. Dunn, Marcel B. Bally	2010	46
11	Rictor and Integrin-Linked Kinase Interact and Regulate Akt Phosphorylation and Cancer Cell Survival Cancer Research ·Paul C. McDonald, Arusha Oloumi, Julia Mills, Iveta Dobreva, Mykola Maidan, Virginia Gray, Elizabeth D. Wederell, Marcel B. Bally, Leonard J. Foster, Shoukat Dedhar	2008	185
12	Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs Molecular Cancer Therapeutics ·Gigi N.C. Chiu, Lincoln Edwards, Anita I. Kapanen, Melina M. Malinen, Wieslawa H. Dragowska, Corinna Warburton, Ghania Chikh, Takanori Satou, Sophia T. Tan, Спасков Сергей Александрович, Saumya Arora, Dawn Waterhouse, Richard Klasa, Marcel B. Bally	2007	51
13	Enhanced liposomal retention of irinotecan is correlated to increases in plasma irinotecan AUC and improved efficacy against a model of colorectal cancer Cancer Research ·Euan Ramsay, Oladunni M Ayodele, Malathi Anantha, Hong Yan, Marcel B. Bally	2005	1
14	Synergistic antitumor activity observed for a fixed ratio liposome formulation of Cytarabine (Cyt):Daunorubicin (Daun) against preclinical leukemia models Cancer Research ·Sharon A. Johnstone, Pierrot Harvie, Madaeni Seyed Siavosh, Salam Kadhim, Troy O. Harasym, Paul Tardi, Natashia Harasym, Marcel B. Bally, Lawrence D. Mayer	2005	3
15	A pharmaceutical approach to achieve synergy in vivo: A fixed ratio formulation of Irinotecan and Floxuridine for treatment of colorectal cancer Cancer Research ·Lawrence D. Mayer, Troy O. Harasym, Natashia Harasym, Paul Tardi, Yu Shu, 麻穂岸本, María C. Espíndola, Marcel B. Bally	2004	2
16	HER-2/neuOverexpression Increases the Viable Hypoxic Cell Population within Solid Tumors without Causing Changes in Tumor Vascularization Molecular Cancer Research ·Wieslawa H. Dragowska, Corinna Warburton, Donald T. Yapp, Andrew I. Minchinton, Yanping Hu, Dawn Waterhouse, Karen A. Gelmon, Kirsten A. Skov, Janet Woo, Dana Masin, Lynsey A. Huxham, Alastair H. Kyle, Marcel B. Bally	2004	23
17	A novel approach to prepare a liposomal irinotecan formulations that exhibit significant therapeutic activity in vivo Cancer Research ·Euan Ramsay, Oladunni M Ayodele, Malathi Anantha, Awa Dicko, Pierrot Harvie, Lawrence D. Mayer, Marcel B. Bally, Paul Tardi	2004	1
18	Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metal-ion-chelating lipids Biochimica et Biophysica Acta (BBA) - Biomembranes ·Ghania Chikh, Wai Ming Li, Puntira Henglai, Jean‐Claude Meunier, Marcel B. Bally	2002	54
19	Efficient Delivery of Antennapedia Homeodomain Fused to CTL Epitope with Liposomes into Dendritic Cells Results in the Activation of CD8+ T Cells The Journal of Immunology ·Ghania Chikh, Spencer Kong, Marcel B. Bally, Jean‐Claude Meunier, Puntira Henglai	2001	48
20	Liposomal Lipid and Plasmid DNA Delivery to B16/BL6 Tumors after Intraperitoneal Administration of Cationic Liposome DNA Aggregates Journal of Pharmacology and Experimental Therapeutics ·Dorothy L. Reimer, Spencer Kong, Myrna A. Monck, 侯文会, Pat Tam, Ellen K. Wasan, Marcel B. Bally	1999	22

About Marcel B. Bally

Marcel B. Bally is a scholar working on Biomaterials, Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology and Allergy, having authored 263 papers that have together received 15.3k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (96 papers), RNA Interference and Gene Delivery (68 papers), Advanced biosensing and bioanalysis techniques (45 papers), Lipid Membrane Structure and Behavior (41 papers), Monoclonal and Polyclonal Antibodies Research (24 papers), Cancer therapeutics and mechanisms (17 papers), Cancer Treatment and Pharmacology (17 papers) and Nanoplatforms for cancer theranostics (15 papers). The work is most often cited by research in Biomaterials (5.4k citations), Pharmaceutical Science (927 citations), Molecular Biology (9.3k citations), Oncology (2.4k citations) and Biomedical Engineering (2.8k citations). Marcel B. Bally has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include Pieter R. Cullis, Lawrence D. Mayer, Michael J. Hope, G. A. Webb, Dana Masin, L.D. Mayer, Thomas D. Madden, Dawn Waterhouse, Paul Tardi and Wieslawa H. Dragowska. Their work appears in journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, Cancer Research, Cancer Chemotherapy and Pharmacology, Journal of Controlled Release and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact